+44 (0) 1223 755950
+1 832 327 7413
Click on the image to see the image legend
Target | Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Spike Protein RBD (Delta B.1.617.2 Variant) |
Origin | Virus |
Expression | Recombinant |
Tested Applications | ELISA, WB |
Host | Insect |
Recommended dilutions | Optimal dilutions/concentrations should be determined by the end user. |
Conjugation | Unconjugated |
Form | Liquid |
Purity | ≥ 90% (SDS-PAGE) |
Purification | Purified by affinity chromatography. |
Storage | Aliquot and store at -20 °C. Avoid repeated freeze/thaw cycles. |
Molecular Weight | Calculated MW: 26 kDa Observed MW (12% reducing SDS-PAGE): 28 kDa. Difference is due to glycosylation. |
Sequence | The amino acid sequence is proprietary. |
Tag | His tag |
Buffer | PBS, pH 7.4. Does not contain preservatives. |
Concentration | 3.9 mg/ml |
Availability | Shipped within 10-20 working days. |
Note | This product is for research use only. This product is shipped with dry ice. |
Directions for use | Centrifuge before opening to ensure complete recovery of vial contents. |